The center aims to create new medicines and innovative treatment materials by pursuing the synthesis of sequence-defined chemical polymers.
The research will be conducted by a team of chemists, biologists, engineers and data scientists in 14 laboratories at UC Berkeley, New Haven, Conn.-based Yale University, Stanford (Calif.) University, Ithaca, N.Y.-based Cornell University, Boston College and Chicago-based St. Jude Children’s Research Hospital.
More articles on health IT:
5 Epic program execs share tips on optimization during times of crisis
5 hospital-at-home initiatives from Adventist Health, Mayo Clinic & more
NIH boosts genomics initiatives with $75M funding
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
